Isatuximab Subcutaneous by On-Body Delivery System vs Isatuximab Intravenous Plus Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Phase 3 IRAKLIA Study.

Journal:

Journal of Clinical Oncology

Published:

2025-06-04

DOI:

10.1200/jco-25-00744

Affiliations:

34

Authors:

32

Go to article

Institutions	Authors	Share
Sanofi US, United States of America (USA)	3.000000	0.09
Sanofi, France	2.000000	0.06
Tongji Hospital (TJH), HUST, China	1.000000	0.03
Norfolk and Norwich University Hospitals NHS Foundation Trust, United Kingdom (UK)	1.000000	0.03
Inmunocel, Chile	1.000000	0.03
Spartanburg Medical Center, United States of America (USA)	1.000000	0.03
Oslo University Hospital (OUS), Norway	1.000000	0.03
Heidelberg University Hospital at Medical Faculty Heidelberg, Uni Heidelberg, Germany	1.000000	0.03
Instituto Alexander Fleming, Argentina	1.000000	0.03
Hôpital Maisonneuve-Rosemont (HMR), Canada	1.000000	0.03
University Hospital Nantes (CHU de Nantes), France	1.000000	0.03
Alfred Health, Australia	1.000000	0.03
Clínica São Germano, Brazil	1.000000	0.03
Federico II University Hospital (FOUND), UNINA, Italy	1.000000	0.03
Illawarra Shoalhaven Local Health District (ISLHD), Australia	1.000000	0.03
Peking University People's Hospital, PKUHSC, China	1.000000	0.03
Istanbul University, Turkey	1.000000	0.03
Centre d’Investigation Clinique de Poitiers (CIC de Poitiers), France	1.000000	0.03
Medical University of Lublin, Poland	1.000000	0.03
Mayo Clinic's Campus in Florida, United States of America (USA)	1.000000	0.03
University Hospital Olomouc, PU, Czech Republic	1.000000	0.03
Japanese Red Cross Medical Center, Japan	1.000000	0.03
Sydney Adventist Hospital, Australia	1.000000	0.03
ShanghaiTech University, China	1.000000	0.03
Hospital Universitario de Salamanca (HUS), USAL, Spain	1.000000	0.03
Charles University (CU), Czech Republic	0.500000	0.02
General University Hospital in Prague, Czech Republic	0.500000	0.02
Somogy County Kaposi Mór Teaching Hospital, Hungary	0.500000	0.02
Korea University, South Korea	0.500000	0.02
University of Pécs (PTE), Hungary	0.500000	0.02
National and Kapodistrian University of Athens (UOA), Greece	0.500000	0.02
Catalan Institute of Oncology (ICO), Spain	0.500000	0.02
Germans Trias i Pujol University Hospital (HUGTP), ICS, Spain	0.500000	0.02

Interested in Oncology and Carcinogenesis?